Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Polycystic Ovary Syndrome × Surveys and Questionnaires × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 43 Neoplasms 25 Prostatic Neoplasms 22 Lung Neoplasms 11 Head and Neck Neoplasms 11 Pancreatic Neoplasms 8 Ovarian Neoplasms 7 Colorectal Neoplasms 7 Oropharyngeal Neoplasms 6 Hematologic Neoplasms 6 Gastrointestinal Neoplasms 6 Urinary Bladder Neoplasms 5 Neoplasm Metastasis 5 Multiple Myeloma 5 Esophageal Neoplasms 5 Depression 5 Brain Neoplasms 5 Sarcoma 4 Motor Activity 4 Lymphoma 4 Endometrial Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Pain 3 Osteosarcoma 3 Melanoma 3 Genetic Predisposition to Disease 3 Fatigue 3 Communication 3 Chronic Pain 3

Interventions

Metformin 18 Inositol 12 Letrozole 7 Tablets 3 Exercise 3 Estradiol 3 semaglutide 2 maltodextrin 2 drospirenone and ethinyl estradiol combination 2 artenimol 2 Spironolactone 2 Progesterone 2 Magnesium 2 Liraglutide 2 Ethinyl Estradiol 2 Docosahexaenoic Acids 2 Diet Therapy 2 Contraceptives, Oral, Combined 2 Clomiphene 2 Caloric Restriction 2 salicylsalicylic acid 1 mirabegron 1 ganirelix 1 etonogestrel 1 empagliflozin 1 drospirenone 1 cetrorelix 1 Walking 1 Transcranial Direct Current Stimulation 1 Thyroxine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07274202 2025-12-10

QolART

Universitair Ziekenhuis Brussel

Phase NA Not yet recruiting

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡